{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:44:44Z","timestamp":1773236684044,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1006\/gyno.2001.6313","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T22:50:18Z","timestamp":1032303018000},"page":"435-441","source":"Crossref","is-referenced-by-count":126,"title":["Procedures Required to Accomplish Complete Cytoreduction of Ovarian Cancer: Is There a Correlation with \u201cBiological Aggressiveness\u201d and Survival?"],"prefix":"10.1006","volume":"82","author":[{"given":"Scott M.","family":"Eisenkop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick M.","family":"Spirtos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2001.6313_RF1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0039-6109(16)41440-4","article-title":"Intensive surgical and chemotherapeutic management of advanced ovarian cancer","volume":"58","author":"Griffiths","year":"1978","journal-title":"Surg Clin North Am"},{"key":"10.1006\/gyno.2001.6313_RF2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1998.4955","article-title":"Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study","volume":"69","author":"Eisenkop","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/gyno.1995.1027","article-title":"The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer","volume":"56","author":"Makar","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0090-8258(92)90107-T","article-title":"The impact of subspecialty training on the management of advanced ovarian cancer","volume":"47","author":"Eisenkop","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0090-8258(92)90100-W","article-title":"The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study","volume":"47","author":"Hoskins","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/gyno.2000.5926","article-title":"A critique of surgical cytoreduction in advanced ovarian cancer","volume":"78","author":"Covens","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0090-8258(90)90415-H","article-title":"Electrosurgical debulking for ovarian cancer: a new technique using the argon beam coagulator","volume":"39","author":"Brand","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/gyno.1993.1277","article-title":"Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival","volume":"51","author":"Eisenkop","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0090-8258(89)90074-7","article-title":"Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer","volume":"35","author":"Montz","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0090-8258(90)90420-P","article-title":"Occult pleural involvement in stage III ovarian carcinoma: role of diaphragmatic resection","volume":"39","author":"Kapnick","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF11","first-page":"879","article-title":"Modified posterior exenteration for ovarian cancer","volume":"78","author":"Eisenkop","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2001.6313_RF12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0002-9378(92)91345-B","article-title":"The cavitronal ultrasonic surgical aspirator for cytoreduction in advanced ovarian cancer","volume":"166","author":"Rose","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2001.6313_RF13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0090-8258(88)90298-3","article-title":"Debulking surgery for ovarian cancer with the Cavitron ultrasonic surgical aspirator (CUSA)\u2014a preliminary report","volume":"31","author":"Deppe","year":"1988","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/gyno.1995.1061","article-title":"Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy","volume":"56","author":"Spirtos","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF15","first-page":"1","article-title":"Technique and feasibility of radical para-aortic and pelvic lymphadenectomy for gynecologic malignancies: a prospective study","volume":"133","author":"Benedetti-Panici","year":"1991","journal-title":"Int J Gynecol Cancer"},{"key":"10.1006\/gyno.2001.6313_RF16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/gyno.1997.4825","article-title":"Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival","volume":"67","author":"Friedman","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF17","first-page":"413","article-title":"Primary cytoreductive surgery for ovarian cancer","volume":"61","author":"Hacker","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2001.6313_RF18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.5842","article-title":"Complete cytoreduction: is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease?","volume":"78","author":"Naik","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF19","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2001.6313_RF20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0090-8258(90)90277-R","article-title":"Primary surgical therapy for ovarian cancer: how much and when","volume":"40","author":"Potter","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1006\/gyno.1993.1040","article-title":"The validity and significance of substages of advanced ovarian cancer","volume":"48","author":"Partridge","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1200\/JCO.1989.7.4.457","article-title":"Randomized trial of cyclophosphamide plus cisplatin with or without doxirubicin in ovarian carcinoma: a Gynecologic Oncology Group study","volume":"7","author":"Omura","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2001.6313_RF23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1006\/gyno.1997.4839","article-title":"Does debulking surgery improve survival in biologically aggressive ovarian cancer","volume":"67","author":"Le","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/gyno.1994.1257","article-title":"The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery","volume":"55","author":"Farias-Eisner","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6313_RF25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared to paclitaxel and cisplatin in Stage III and IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2001.6313_RF26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<159::AID-CNCR20>3.0.CO;2-0","article-title":"The clinical predictivity of biomarkers of Stage III\u2013IV epithelial ovarian cancer in a prospective randomized treatment protocol","volume":"82","author":"Silvestrini","year":"1998","journal-title":"Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801963139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801963139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T18:56:26Z","timestamp":1557341786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825801963139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["S0090825801963139"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2001.6313","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}